Voltage-Gated, Ph-Sensitive Anion Channel And Its Novel Splice Variant Involved In Taste Sensation
AssigneeMonell Chemical Senses Center
InventorsLiquan Huang, Jie Cao, Hong Wang, Joseph G. Brand
Life of this patent
Estimating the term…
Abstract
The invention provides a novel splice-variant of the ClC-4 protein, termed ClC-4A. ClC-4A is expressed in taste bud cells and is involved in sour taste perception. The invention provides ClC-4A polynucleotides and ClC-4A polypeptides, vectors, host cells and ClC-4A specific antibodies as well as designing high potency taste stimuli, determining taste preferences in animals, developing breed-specific foods, and modifying the taste of foods and medications.
Claims52
An isolated polynucleotide comprising a sequence selected from the group consisting of:
- SEQ ID NO:6, SEQ ID NO:11 and a sequence encoding a polypeptide wherein said polypeptide consists of the amino acid sequence of SEQ ID NO:8 and variants thereof.
A method for identifying taste modifiers comprising contacting a ClC-4A polypeptide with a potential taste modifier and measuring the binding of said potential taste modifier to said ClC-4A polypeptide with respect to the binding of a natural ligand to ClC4-A.
A method for diagnosing a ClC4-A-related disease comprising contacting a test biological sample with a polynucleotide that specifically hybridizes to a nucleic acid encoding a ClC4-A polypeptide and determining the expression level of said nucleic acid, wherein a variation from expression of said nucleic acid from a known normal biological sample indicates a ClC4-A disease state.
A method for developing a food specific for a breed of animal comprising admixing a compound that specifically binds to a ClC-4A of said breed of animal with a dietary preparation wherein said compound is perceived as palatable by the breed of animal and is present in an amount sufficient to modify the perceived taste of said dietary preparation.
A dietary preparation comprising a taste modifying amount of a compound that specifically binds to a ClC4-A protein.
A method for modulating the taste of a medication comprising adding a taste-modifying amount of a compound to said medication wherein said compound specifically binds to a ClC4-A polypeptide and is perceived as palatable by a patient to which the medicine is administered.
A method for enhancing the efficient use of nutrients comprising administering to an animal at least one compound that modulates ClC-4 or ClC-4A activity.
A method for determining taste preference in an animal comprising determining the relative expression of ClC-4A in said animal as compared with the expression of ClC-4 wherein higher expression of ClC-4A in said animal correlates to an increased sensitivity to sour taste and a propensity to preferring foods with high potency sweeteners.
A method for designing a high potency taste stimulus for ClC-4A comprising determining the binding affinity of a test compound to a ClC-4A polypeptide and modeling a second compound based on the structural features of a test compound with high affinity for ClC-4A, thereby designing a high potency taste stimulus for ClC-4A.
A transgenic animal comprising a polynucleotide sequence encoding a heterologous ClC-4A polypeptide.
A method of making a ClC-4A transgenic animal comprising introducing into an animal a heterologous polynucleotide encoding a ClC-4A polypeptide operably linked to expression control sequences.
An antibody or antigen binding portion thereof that specifically binds to a ClC-4A polypeptide.
A method of identifying novel agonists of ClC-4 or ClC-4A comprising comparing the primary amino acid sequence of ClC-4 or ClC-4A to other chloride channel sequences, deducing a three dimensional structure for ClC-4 or ClC-4A based on known structure of said other chloride channels, and designing molecules to fit into a ligand-binding portion of ClC-4 or ClC-4A, thereby identifying novel agonists of ClC-4 or ClC-4A.
A method of identifying novel antagonists of ClC-4 or ClC-4A comprising comparing the primary amino acid sequence of ClC-4 or ClC-4A to other chloride channel sequences, deducing a three dimensional structure for ClC-4 or ClC-4A based on known structure of said other chloride channels, and designing molecules to fit into a ligand-binding portion of ClC-4 or ClC-4A and prevent ligands from binding to the ligand binding portion of CLC-4 or ClC-4A, thereby identifying novel antagonists of ClC-4 or ClC-4A.
Dependencies are inferred from the claim text.